VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3310
ETF rank
ยฃ18.37 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
ยฃ21.12
Share price
-0.50%
Change (1 day)
26.52%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of October 2026: 0.35%